GILD vs RVMD: stock comparison and AI forecast
Gilead Sciences, Inc. (GILD) and Revolution Medicines, Inc. (RVMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GILD Gilead Sciences, Inc.
- Price
- $174.48 +28.0% · 6M
- Market Cap
- $207.84B
- P/E Ratio
- –
- Size
- mega-cap
- AI Forecast
RVMD Revolution Medicines, Inc.
- Market Cap
- $42.80B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GILD is 4.9 times larger than RVMD by market capitalization ($207.84B against $42.80B).
- GILD turns -12.5% of its revenue into net income, against -946.8% for RVMD.
- GILD carries 2.95 times debt per unit of equity, against 0.79 times for RVMD.
- GILD yields 1.97% in dividends; RVMD pays none.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GILD | RVMD |
|---|---|---|
| Market Cap | $207.84B | $42.80B |
| P/B Ratio | 15.94x | 17.82x |
| Dividend Yield | 1.97% | – |
| EPS | $-3.15 | $-9.15 |
| Book Value/Share | $10.51 | $11.20 |
| Revenue/Share | $24.98 | – |
| FCF/Share | $11.11 | $-6.72 |
Profitability & Margins
| Metric | GILD | RVMD |
|---|---|---|
| ROE | -29.6% | -77.9% |
| ROA | -7.5% | -43.5% |
| ROIC | -6.0% | -44.0% |
| Gross Margin | 79.9% | – |
| Operating Margin | -7.6% | -853.0% |
| Net Margin | -12.5% | -946.8% |
| EBT Margin | -8.2% | -948.0% |
| Tax Rate | -52.5% | 0.2% |
Financial Health
| Metric | GILD | RVMD |
|---|---|---|
| Current Ratio | 1.38x | 8.36x |
| Quick Ratio | 1.22x | 8.34x |
| D/E Ratio | 2.95x | 0.79x |
| Financial Leverage | 3.94x | 1.79x |
| Interest Coverage | 1.9x | -3116.4x |
| Working Capital | $4.55B | $3.50B |
Cash Flow
| Metric | GILD | RVMD |
|---|---|---|
| Operating Cash Flow | $14.48B | -$1.43B |
| Free Cash Flow | $13.78B | -$1.44B |
| Capital Spending | -$699M | -$9M |
| OCF Growth YoY | 49.8% | – |
| FCF Growth YoY | 50.4% | – |
| FCF/Sales | 44.5% | – |
| CapEx/Sales | 2.3% | – |
Operational Efficiency
| Metric | GILD | RVMD |
|---|---|---|
| Asset Turnover | 0.60x | – |
| Receivables Turnover | 6.2x | – |
| Inventory Turnover | 3.3x | – |
| Fixed Assets Turnover | 5.2x | – |
| Days Sales Outstanding | 59 days | – |
| Days Inventory | 111 days | – |
| Payables Period | 55 days | – |
| Cash Conversion Cycle | 115 days | – |
Income Statement
| Metric | GILD | RVMD |
|---|---|---|
| Total Revenue | $30.99B | – |
| Operating Income | -$2.36B | -$1.69B |
| Net Income | -$3.86B | -$1.87B |
| R&D Expense | $6.33B | $1.45B |
| SG&A Expense | $6.81B | – |
| Cost of Goods Sold | $6.22B | – |
Dividend & Shareholder Information
| Metric | GILD | RVMD |
|---|---|---|
| Dividends Per Share | $3.31 | – |
| Shares Outstanding | 1240M | 214M |
| Net Income Growth | -147.6% | – |
| EPS Growth | -148.8% | – |
GILD vs RVMD: stock comparison and AI forecast
Which is bigger, GILD or RVMD?
GILD is 4.9 times larger than RVMD by market capitalization ($207.84B against $42.80B).
Which one does Intratio's AI model rank higher, GILD or RVMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.